Scholar Rock Holding Corp financial data

Symbol
SRRK on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
301 Binney Street, 3 Rd Floor, Cambridge, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 741 % -27.5%
Debt-to-equity 48.9 % +32.4%
Return On Equity -115 % -77%
Return On Assets -77.2 % -62.8%
Operating Margin -232 % +63.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80M shares +42.3%
Common Stock, Shares, Outstanding 80M shares +45%
Entity Public Float 158M USD +44.6%
Common Stock, Value, Issued 80K USD +45.5%
Weighted Average Number of Shares Outstanding, Basic 96.8M shares +20.8%
Weighted Average Number of Shares Outstanding, Diluted 96.8M shares +20.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 47.3M USD +214%
Research and Development Expense 151M USD +26.1%
General and Administrative Expense 58.9M USD +32.9%
Operating Income (Loss) -210M USD -27.9%
Nonoperating Income (Expense) 5.78M USD +43.5%
Net Income (Loss) Attributable to Parent -204M USD -27.5%
Earnings Per Share, Basic -2.22 USD/shares -13.8%
Earnings Per Share, Diluted -2.22 USD/shares -13.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 93.4M USD -13.6%
Marketable Securities, Current 97.1M USD -31%
Assets, Current 199M USD -23.4%
Property, Plant and Equipment, Net 3.55M USD -40.8%
Operating Lease, Right-of-Use Asset 18M USD +20.8%
Other Assets, Noncurrent 3.8M USD +137%
Assets 227M USD -20.4%
Accounts Payable, Current 3.32M USD +8.9%
Employee-related Liabilities, Current 7.35M USD +30.5%
Accrued Liabilities, Current 21.9M USD +58.5%
Liabilities, Current 33M USD +35.9%
Operating Lease, Liability, Noncurrent 11.8M USD +43.1%
Liabilities 93.2M USD +13.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -54K USD +14.3%
Retained Earnings (Accumulated Deficit) -792M USD -34.7%
Stockholders' Equity Attributable to Parent 134M USD -34%
Liabilities and Equity 227M USD -20.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.8M USD -15.6%
Net Cash Provided by (Used in) Financing Activities 6.53M USD +506%
Net Cash Provided by (Used in) Investing Activities 33.4M USD -62.9%
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 80M shares +45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.88M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 95.8M USD -13.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD +11.1%
Deferred Tax Assets, Valuation Allowance 217M USD +29.4%
Deferred Tax Assets, Gross 220M USD +27.2%
Operating Lease, Liability 11.8M USD -40%
Payments to Acquire Property, Plant, and Equipment 23K USD -23.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -204M USD -27.5%
Lessee, Operating Lease, Liability, to be Paid 12.5M USD -41.9%
Property, Plant and Equipment, Gross 15.9M USD -9.59%
Operating Lease, Liability, Current 6.2M USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.5M USD -44.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.05M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +78.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 749K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.5M USD -44.1%
Deferred Tax Assets, Operating Loss Carryforwards 110M USD +17.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.98M USD -15.4%
Additional Paid in Capital 925M USD +17.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.76M USD -35.9%
Share-based Payment Arrangement, Expense 31.6M USD +16.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%